Nih Authorizes First Human Trial Of Crispr Gene-editing Technique

Forget GMO. Get ready for GMH. CRISPR, the genome-editing technology that has taken biomedical science by storm, is finally nearing human trials. On 21 June, an advisory committee at the US National Institutes of Health (NIH) approved a proposal to use CRISPR–Cas9 to help augment cancer therapies that rely on enlisting a patient’s T cells, a type of immune cell. Where some gene modification techniques have involved the brute-force insertion of genetic material (including shooting at cells with an air pistol), CRISPR is a much more exacting technique that offers multiple approaches to carefully editing genes, including human genes. What CRISPR offers, and biologists desire, is specificity: the ability to target and study particular DNA sequences in the vast expanse of a genome.

BING NEWS:
  • Generative A.I. Arrives in the Gene Editing World of CRISPR
    Much as ChatGPT generates poetry, a new A.I. system devises blueprints for microscopic mechanisms that can edit your DNA.
    04/22/2024 - 9:48 am | View Link
  • Profluent Successfully Edits Human Genome with OpenCRISPR-1, the World’s First AI-Created and Open-Source Gene Editor
    With this launch, Profluent demonstrates the first successful precision editing of the human ... in gene editing, with the goal of pulling this future forward, we are open-sourcing the products of ...
    04/22/2024 - 5:30 am | View Link
  • CRISPR Gene-Editing Company Caszyme Opens New Facility
    It has been estimated that the global size of the gene editing market could reach $29.93 billion by the year 2032.
    04/10/2024 - 11:59 am | View Link
  • Gene Editing Breakthrough: CRISPR-Cas9 Successfully Excises HIV from T-cells in Major Research Leap
    The CRISPR-Cas9 genome editing tool has demonstrated the capability to eradicate HIV viruses from cells cultured in laboratory settings, as per preliminary research slated for presentation at this ...
    04/9/2024 - 4:03 pm | View Link
  • A Bold Gene-Editing Solution Began Testing—Then Hit the Strangest Twist
    The Boston-based biotech firm Verve Therapeutics recently had to pause a clinical trial after a participating patient developed an unforeseen side effect to the gene-editing serum. The company says ...
    04/9/2024 - 1:00 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Politics News